4.6 Review

Global challenges and policy solutions in breast cancer control

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

The Global Macroeconomic Burden of Breast Cancer Implications for Oncologic Surgery

Kavitha Ranganathan et al.

Summary: The study revealed that breast cancer mortality rates are significantly higher in low and middle-income countries, with the economic burden increasing over time. Efforts to improve access to surgical care for breast cancer patients globally could reduce mortality rates and alleviate the social and economic impact of the disease in low and middle-income countries.

ANNALS OF SURGERY (2021)

Article Health Policy & Services

The global landscape of drug development of trastuzumab biosimilars

Dario Trapani et al.

Summary: The development of biosimilars is significantly focused in low- and middle-income countries. In countries where no biosimilars are approved, there is more representation in the drug development of biosimilars. Therefore, the research and development of biosimilars should be aligned with national priorities in cancer control.

JOURNAL OF CANCER POLICY (2021)

Article Health Policy & Services

The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: The ONCOLLEGE-001 survey

D. Trapani et al.

Summary: The study investigated the accessibility and affordability of essential care for breast cancer patients, revealing significant financial barriers and high costs of HER2 testing in low-income countries.

JOURNAL OF CANCER POLICY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis

Catherine Duggan et al.

Summary: Some countries have seen significant reduction in breast cancer mortality rates through increased coverage of essential health services and higher number of public cancer centers. Early diagnosis programs are crucial for improving breast cancer outcomes.

LANCET ONCOLOGY (2021)

Review Oncology

The Global Landscape of Treatment Standards for Breast Cancer

Dario Trapani et al.

Summary: Breast cancer treatment guidelines mainly come from English-speaking European and American regions, with half of the guidelines failing to achieve gender balance in authorship. Resource-stratified approaches are adopted in some resource-constrained settings, but national guidelines may not adequately consider local health-system capacity.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey

Adam Fundytus et al.

Summary: The study investigated the alignment of cancer medicines in the WHO Essential Medicines List with the priorities of frontline oncologists worldwide, as well as the accessibility of these medicines in different countries. The findings reveal significant barriers in access to core cancer medicines globally, emphasizing the urgent need for policy action to ensure patients with cancer have access to essential medicines.

LANCET ONCOLOGY (2021)

Review Oncology

Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review

Parsa Erfani et al.

Summary: There has been significant growth in breast cancer economic evaluations in low- and middle-income countries (LMICs) in the past decade, but data from low-income countries, especially those in Sub-Saharan Africa, remain limited. Prioritizing breast cancer economic evaluations in these countries and striving to use and report a comprehensive cost perspective and time horizon is crucial for guiding effective care delivery strategies. Utilizing existing frameworks for economic evaluations in LMICs may facilitate comparable and transparent costing analyses to inform breast cancer control strategies.

ONCOLOGIST (2021)

Editorial Material Public, Environmental & Occupational Health

COVID-19 pandemic and health-care disruptions: count the most vulnerable

Jogender Kumar et al.

LANCET GLOBAL HEALTH (2021)

Article Oncology

Assessment of Breast Cancer Management in Sub-Saharan Africa

Verna Vanderpuye et al.

Summary: The survey conducted among AORTIC members in 2018 showed positive progress in breast cancer management in sub-Saharan Africa, with an increase in oncologist respondents, radiotherapy facilities, and availability of certain treatments. However, challenges such as sociocultural and economic barriers, system delays, and advanced stage at presentation still persist. Expanding the workforce and prioritizing quality of care are important steps to further improve outcomes.

JCO GLOBAL ONCOLOGY (2021)

Review Oncology

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review

Rachel Riera et al.

Summary: The study identified a high frequency of delays and disruptions in cancer care services globally due to the reduction in service availability caused by the COVID-19 pandemic. Various categories of delays and disruptions were found to impact cancer treatment, diagnosis, and general health services.

JCO GLOBAL ONCOLOGY (2021)

Editorial Material Oncology

How can biosimilars change the trajectory of breast cancer therapy?

Dario Trapani et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2020)

Article Public, Environmental & Occupational Health

A Syndemic Perspective on the Management of Non-communicable Diseases Amid the COVID-19 Pandemic in Low- and Middle-Income Countries

Uday Narayan Yadav et al.

FRONTIERS IN PUBLIC HEALTH (2020)

Article Public, Environmental & Occupational Health

Comparison of essential medicines lists in 137 countries

Nav Persaud et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2019)

Article Medicine, General & Internal

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012

Sylvia K. Plevritis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Public, Environmental & Occupational Health

The Lancet Commission on Palliative Care and Pain Relief—findings, recommendations, and future directions

Felicia M Knaul et al.

Lancet Global Health (2018)

Review Oncology

National cancer control plans: a global analysis

Yannick Romero et al.

LANCET ONCOLOGY (2018)

Review Oncology

Breast Cancer Disparities Among Women in Low- and Middle-Income Countries

O. Ginsburg et al.

CURRENT BREAST CANCER REPORTS (2018)

Article Medicine, General & Internal

The global burden of women's cancers: a grand challenge in global health

Ophira Ginsburg et al.

LANCET (2017)

Editorial Material Public, Environmental & Occupational Health

Reframing non-communicable diseases as socially transmitted conditions

Luke N. Allen et al.

LANCET GLOBAL HEALTH (2017)

Article Oncology

Long-Term Economic and Employment Outcomes Among Partners of Women With Early-Stage Breast Cancer

Christine M. Veenstra et al.

JOURNAL OF ONCOLOGY PRACTICE (2017)

Article Public, Environmental & Occupational Health

Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer

Rulla M. Tamimi et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)

Article Public, Environmental & Occupational Health

Productivity Costs Associated With Breast Cancer Among Survivors Aged 18-44 Years

Donatus U. Ekwueme et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2016)

Review Multidisciplinary Sciences

Economic Benefits of Investing in Women's Health: A Systematic Review

Kristine Husoy Onarheim et al.

PLOS ONE (2016)

Article Oncology

International Variation in Female Breast Cancer Incidence and Mortality Rates

Carol E. DeSantis et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)

Meeting Abstract Oncology

Socioeconomic impact of breast cancer survivors.

Hideko Yamauchi et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Medicine, General & Internal

Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis

Mohammad H. Forouzanfar et al.

LANCET (2011)